Karuna Therapeutics Ownership 2024 | Who Owns Karuna Therapeutics Now?
Institutional Ownership
0.00%
Insider Ownership
4.99%
Retail Ownership
95.01%
Institutional Holders
3.00
Karuna Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -817 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -88 | -100.00% | - | Jun 30, 2024 |
| SACHETTA, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Karuna Therapeutics's largest institutional shareholder is IFP ADVISORS, INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -817 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -88 | -100.00% | - | Jun 30, 2024 |
| SACHETTA, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
The largest Karuna Therapeutics shareholder by % of total assets is IFP ADVISORS, INC. The company owns 0.00 shares of Karuna Therapeutics (KRTX), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SACHETTA, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -88 | -100.00% | - | Jun 30, 2024 |
| IFP ADVISORS, INC | - | - | - | -817 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Karuna Therapeutics's largest institutional buyer is SACHETTA, LLC. The company purchased -1.00 stocks of KRTX, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -817 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -88 | -100.00% | - | Jun 30, 2024 |
| SACHETTA, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Karuna Therapeutics's biggest institutional seller is IFP ADVISORS, INC. The company sold -0.82K shares of KRTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IFP ADVISORS, INC | - | - | - | -817 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -88 | -100.00% | - | Jun 30, 2024 |
| SACHETTA, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Karuna Therapeutics's largest sold out institutional shareholder by shares sold is IFP ADVISORS, INC, sold -0.82K shares, valued at -, as of undefined.
Karuna Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Manager Directed Portfolios | 0.32% | 52,879 | - | - | Jan 31, 2024 |
| Fiera Capital Series Trust | 0.31% | 6,241 | -207 | -3.21% | Jun 30, 2023 |
| Capital Group Growth ETF | 0.15% | 58,608 | - | - | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.14% | 471,717 | - | - | Mar 31, 2024 |
| T. Rowe Price All-Cap Opportunities Fund, Inc. | 0.11% | 209,217 | - | - | Mar 31, 2024 |
| Clough Global Equity Fund | 0.11% | 6,650 | - | - | Jan 31, 2024 |
| Capital Group U.S. Equity Fund | 0.08% | 2,800 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.07% | 2,093,897 | - | - | Feb 29, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.07% | 66,261 | - | - | Jan 31, 2024 |
| UBS RELATIONSHIP FUNDS | 0.07% | 16,696 | - | - | Jun 30, 2020 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.07% | 239,633 | - | - | Mar 31, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.06% | 22,453 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.06% | 320,132 | - | - | Mar 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.06% | 93,884 | - | - | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.06% | 177,489 | - | - | Mar 31, 2024 |
| Comstock Funds, Inc. | 0.05% | 1,100 | 1,100 | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.05% | 12,170 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 388,167 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 22,347 | - | - | Mar 31, 2024 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.04% | 648,500 | - | - | Mar 31, 2024 |
| AltShares Trust | 0.04% | 6,743 | 6,743 | - | Feb 29, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.04% | 76,098 | - | - | Feb 29, 2024 |
| Gabelli 787 Fund, Inc. | 0.04% | 3,000 | 3,000 | - | Jan 31, 2024 |
| Clough Global Opportunities Fund | 0.03% | 11,380 | - | - | Jan 31, 2024 |
| IndexIQ ETF Trust | 0.03% | 65,970 | 62,172 | 1636.97% | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.03% | 531,883 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.03% | 42,666 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.03% | 12,032 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.02% | 20,185 | - | - | Mar 31, 2024 |
| NEW PERSPECTIVE FUND | 0.02% | 681,812 | - | - | Mar 31, 2024 |
| ALGER PORTFOLIOS | 0.02% | 8,309 | 1,413 | 20.49% | Dec 31, 2023 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 229,107 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.02% | 158,930 | - | - | Mar 31, 2024 |
| ARBITRAGE FUNDS | 0.02% | 91,937 | 91,937 | - | Feb 29, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.02% | 900,108 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 63,055 | -837 | -1.31% | Jan 31, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.02% | 1,500 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.01% | 322 | -15 | -4.45% | Dec 31, 2023 |
| AMERICAN FUNDS FUNDAMENTAL INVESTORS | 0.01% | 279,186 | - | - | Mar 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.01% | 12,164 | - | - | Feb 29, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.01% | 4,245 | - | - | Mar 31, 2024 |
| GROWTH FUND OF AMERICA | 0.01% | 277,412 | -2,170,997 | -88.67% | Feb 29, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.01% | 5,650 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.01% | 2,618 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 24,672 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 612,842 | - | - | Feb 29, 2024 |
| Voya EQUITY TRUST | 0.01% | 13,405 | - | - | Feb 29, 2024 |
| MERGER FUND | 0.01% | 74,135 | - | - | Mar 28, 2024 |
| WANGER ADVISORS TRUST | 0.01% | 4,932 | - | - | Mar 31, 2024 |
| Nuveen S&P 500 Dynamic Overwrite Fund | 0.01% | 253 | - | - | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.01% | 2,279 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,973 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 51,588 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,467,558 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.01% | 21,581 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.01% | 26,208 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 89,000 | -4,177 | -4.48% | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 478,752 | - | - | Mar 31, 2024 |
| MERGER FUND VL | 0.01% | 924 | - | - | Mar 28, 2024 |
| Virtus Event Opportunities Trust | 0.01% | 15,541 | - | - | Mar 28, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 43,600 | -66,151 | -60.27% | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 1,598,651 | 1,597,789 | 185358.37% | Jan 31, 2024 |
| ALGER FUNDS | 0.00% | 4,109 | -8,654 | -67.81% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 951 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 17,402 | - | - | Mar 31, 2024 |
| Collaborative Investment Series Trust | 0.00% | 643 | - | - | Mar 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.00% | 8,400 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 105,790 | - | - | Mar 31, 2024 |
| GDL FUND | 0.00% | 4,500 | 4,500 | - | Dec 29, 2023 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.00% | 16,869 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 33,623 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 21,998 | -10,379 | -32.06% | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 13,920 | - | - | Jan 31, 2024 |
| Brown Advisory Funds | 0.00% | 108,450 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.00% | 28,908 | -7,671 | -20.97% | Jan 31, 2024 |
| AB CAP FUND, INC. | 0.00% | 87,987 | - | - | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 11,300 | - | - | Mar 31, 2024 |
| PAX WORLD FUNDS SERIES TRUST I | 0.00% | 49,463 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 7,845 | 124 | 1.61% | Feb 29, 2024 |
| CARILLON SERIES TRUST | 0.00% | 129,352 | - | - | Mar 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.00% | 579 | -5,101 | -89.81% | Jan 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.00% | 63,123 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.00% | 5,264 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 21,137 | - | - | Feb 29, 2024 |
| HARBOR FUNDS | 0.00% | 37,658 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 338,186 | 11,473 | 3.51% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 6,579 | 1,105 | 20.19% | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 1,775 | 985 | 124.68% | Dec 31, 2023 |
| T. Rowe Price Capital Appreciation Fund, Inc. | 0.00% | 324,667 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 11,774 | - | - | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 7,938 | 128 | 1.64% | Jan 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 16,020 | - | - | Jan 31, 2024 |
| GABELLI INVESTOR FUNDS INC | 0.00% | 3,000 | 3,000 | - | Dec 29, 2023 |
| Goldman Sachs ETF Trust II | 0.00% | 1,197 | 3 | 0.25% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 31,115 | - | - | Mar 28, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 9,323 | - | - | Mar 28, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 9,776 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,558 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 8,956 | - | - | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 50,062 | - | - | Mar 31, 2024 |
Karuna Therapeutics's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 52.88K shares, compromising 0.32% of its total assets.
Karuna Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 3 | -99.16% |
| 31 Dec, 23 | 359 | 31.02% |
| 30 Sep, 23 | 274 | -11.61% |
| 30 Jun, 23 | 310 | 18.32% |
| 31 Mar, 23 | 262 | - |
| 31 Dec, 22 | 262 | -4.38% |
| 30 Sep, 22 | 274 | 28.04% |
| 30 Jun, 22 | 214 | 15.68% |
| 31 Mar, 22 | 185 | 3.35% |
| 31 Dec, 21 | 179 | 8.48% |
| 30 Sep, 21 | 165 | - |
| 30 Jun, 21 | 165 | - |
| 31 Mar, 21 | 165 | 10.74% |
| 31 Dec, 20 | 149 | 8.76% |
| 30 Sep, 20 | 137 | -1.44% |
| 30 Jun, 20 | 139 | 33.65% |
| 31 Mar, 20 | 104 | 20.93% |
| 31 Dec, 19 | 86 | 72.00% |
| 30 Sep, 19 | 50 | 31.58% |
| 30 Jun, 19 | 38 | - |
As of 31 Mar 24, 3 institutions are holding Karuna Therapeutics's shares, representing a decrease of -99.16% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 906 | -100.00% |
| 31 Dec, 23 | 37,214,897 | -1.67% |
| 30 Sep, 23 | 37,848,839 | 1.28% |
| 30 Jun, 23 | 37,371,235 | -3.34% |
| 31 Mar, 23 | 38,663,544 | 11.66% |
| 31 Dec, 22 | 34,626,876 | 1.80% |
| 30 Sep, 22 | 34,013,375 | 13.93% |
| 30 Jun, 22 | 29,854,786 | 1.20% |
| 31 Mar, 22 | 29,500,552 | 0.79% |
| 31 Dec, 21 | 29,269,081 | 14.04% |
| 30 Sep, 21 | 25,666,026 | -0.42% |
| 30 Jun, 21 | 25,773,295 | 2.36% |
| 31 Mar, 21 | 25,179,621 | 16.74% |
| 31 Dec, 20 | 21,569,656 | 6.75% |
| 30 Sep, 20 | 20,205,704 | 6.83% |
| 30 Jun, 20 | 18,913,335 | 13.10% |
| 31 Mar, 20 | 16,722,290 | 26.29% |
| 31 Dec, 19 | 13,241,316 | 44.67% |
| 30 Sep, 19 | 9,153,047 | 5.62% |
| 30 Jun, 19 | 8,666,326 | - |
Karuna Therapeutics (KRTX) has 906.00 shares outstanding as of 31 Mar 24, down -100.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 0.00% | - |
| 31 Dec, 23 | 100.69% | 1.00% |
| 30 Sep, 23 | 100.42% | 1.01% |
| 30 Jun, 23 | 99.59% | 0.81% |
| 31 Mar, 23 | 111.10% | 1.10% |
| 31 Dec, 22 | 100.64% | 0.91% |
| 30 Sep, 22 | 105.14% | 1.05% |
| 30 Jun, 22 | 99.86% | 1.02% |
| 31 Mar, 22 | 98.98% | 0.98% |
| 31 Dec, 21 | 100.45% | 1.33% |
| 30 Sep, 21 | 86.79% | 1.14% |
| 30 Jun, 21 | 87.42% | 1.06% |
| 31 Mar, 21 | 90.62% | 1.36% |
| 31 Dec, 20 | 81.56% | 1.42% |
| 30 Sep, 20 | 75.78% | 1.45% |
| 30 Jun, 20 | 72.23% | 1.75% |
| 31 Mar, 20 | 64.21% | 2.19% |
| 31 Dec, 19 | 54.20% | 3.39% |
| 30 Sep, 19 | 39.96% | 2.43% |
| 30 Jun, 19 | 40.55% | - |
As of 31 Mar 24, Karuna Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | - | -100.00% |
| 31 Dec, 23 | 219 | 65.91% |
| 30 Sep, 23 | 132 | -21.43% |
| 30 Jun, 23 | 168 | 12.75% |
| 31 Mar, 23 | 149 | 2.76% |
| 31 Dec, 22 | 145 | -18.08% |
| 30 Sep, 22 | 177 | 56.64% |
| 30 Jun, 22 | 113 | 21.51% |
| 31 Mar, 22 | 93 | 5.68% |
| 31 Dec, 21 | 88 | 15.79% |
| 30 Sep, 21 | 76 | -22.45% |
| 30 Jun, 21 | 98 | 24.05% |
| 31 Mar, 21 | 79 | 3.95% |
| 31 Dec, 20 | 76 | 4.11% |
| 30 Sep, 20 | 73 | -26.26% |
| 30 Jun, 20 | 99 | 33.78% |
| 31 Mar, 20 | 74 | 5.71% |
| 31 Dec, 19 | 70 | 125.81% |
| 30 Sep, 19 | 31 | -18.42% |
| 30 Jun, 19 | 38 | - |
- institutional shareholders have increased their position in KRTX stock as of 31 Mar 24 compared to 219 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 1 | -98.89% |
| 31 Dec, 23 | 90 | 2.27% |
| 30 Sep, 23 | 88 | -3.30% |
| 30 Jun, 23 | 91 | 26.39% |
| 31 Mar, 23 | 72 | -4.00% |
| 31 Dec, 22 | 75 | 8.70% |
| 30 Sep, 22 | 69 | 9.52% |
| 30 Jun, 22 | 63 | 10.53% |
| 31 Mar, 22 | 57 | 11.76% |
| 31 Dec, 21 | 51 | 8.51% |
| 30 Sep, 21 | 47 | 14.63% |
| 30 Jun, 21 | 41 | -30.51% |
| 31 Mar, 21 | 59 | 31.11% |
| 31 Dec, 20 | 45 | 15.38% |
| 30 Sep, 20 | 39 | 77.27% |
| 30 Jun, 20 | 22 | 46.67% |
| 31 Mar, 20 | 15 | 25.00% |
| 31 Dec, 19 | 12 | -25.00% |
| 30 Sep, 19 | 16 | - |
| 30 Jun, 19 | - | - |
1 institutional shareholders have reduced their position in KRTX stock as of 31 Mar 24 compared to 90 in the previous quarter (a -98.89% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 3 | -99.16% | 906 | -100.00% | 0.00% | - | - | -100.00% | 1 | -98.89% |
| 31 Dec, 23 | 359 | 31.02% | 37,214,897 | -1.67% | 100.69% | 1.00% | 219 | 65.91% | 90 | 2.27% |
| 30 Sep, 23 | 274 | -11.61% | 37,848,839 | 1.28% | 100.42% | 1.01% | 132 | -21.43% | 88 | -3.30% |
| 30 Jun, 23 | 310 | 18.32% | 37,371,235 | -3.34% | 99.59% | 0.81% | 168 | 12.75% | 91 | 26.39% |
| 31 Mar, 23 | 262 | - | 38,663,544 | 11.66% | 111.10% | 1.10% | 149 | 2.76% | 72 | -4.00% |
| 31 Dec, 22 | 262 | -4.38% | 34,626,876 | 1.80% | 100.64% | 0.91% | 145 | -18.08% | 75 | 8.70% |
| 30 Sep, 22 | 274 | 28.04% | 34,013,375 | 13.93% | 105.14% | 1.05% | 177 | 56.64% | 69 | 9.52% |
| 30 Jun, 22 | 214 | 15.68% | 29,854,786 | 1.20% | 99.86% | 1.02% | 113 | 21.51% | 63 | 10.53% |
| 31 Mar, 22 | 185 | 3.35% | 29,500,552 | 0.79% | 98.98% | 0.98% | 93 | 5.68% | 57 | 11.76% |
| 31 Dec, 21 | 179 | 8.48% | 29,269,081 | 14.04% | 100.45% | 1.33% | 88 | 15.79% | 51 | 8.51% |
| 30 Sep, 21 | 165 | - | 25,666,026 | -0.42% | 86.79% | 1.14% | 76 | -22.45% | 47 | 14.63% |
| 30 Jun, 21 | 165 | - | 25,773,295 | 2.36% | 87.42% | 1.06% | 98 | 24.05% | 41 | -30.51% |
| 31 Mar, 21 | 165 | 10.74% | 25,179,621 | 16.74% | 90.62% | 1.36% | 79 | 3.95% | 59 | 31.11% |
| 31 Dec, 20 | 149 | 8.76% | 21,569,656 | 6.75% | 81.56% | 1.42% | 76 | 4.11% | 45 | 15.38% |
| 30 Sep, 20 | 137 | -1.44% | 20,205,704 | 6.83% | 75.78% | 1.45% | 73 | -26.26% | 39 | 77.27% |
| 30 Jun, 20 | 139 | 33.65% | 18,913,335 | 13.10% | 72.23% | 1.75% | 99 | 33.78% | 22 | 46.67% |
| 31 Mar, 20 | 104 | 20.93% | 16,722,290 | 26.29% | 64.21% | 2.19% | 74 | 5.71% | 15 | 25.00% |
| 31 Dec, 19 | 86 | 72.00% | 13,241,316 | 44.67% | 54.20% | 3.39% | 70 | 125.81% | 12 | -25.00% |
| 30 Sep, 19 | 50 | 31.58% | 9,153,047 | 5.62% | 39.96% | 2.43% | 31 | -18.42% | 16 | - |
| 30 Jun, 19 | 38 | - | 8,666,326 | - | 40.55% | - | 38 | - | - | - |
Karuna Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Karuna Therapeutics's stock was made by Wheadon David E. on Mar 18 2024, selling 990 shares at $330.00 per share (valued at $326.70K).
Karuna Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 18 | 107 | 16.82% |
| Q4 2023 | 6 | 20 | 30.00% |
| Q3 2023 | 11 | 40 | 27.50% |
| Q2 2023 | 20 | 16 | 125.00% |
| Q1 2023 | 25 | 16 | 156.25% |
| Q4 2022 | 15 | 27 | 55.56% |
| Q3 2022 | 8 | 25 | 32.00% |
| Q2 2022 | 28 | 21 | 133.33% |
| Q1 2022 | 14 | 17 | 82.35% |
| Q4 2021 | 14 | 35 | 40.00% |
| Q3 2021 | 12 | 22 | 54.55% |
| Q2 2021 | 25 | 32 | 78.13% |
| Q1 2021 | 16 | 20 | 80.00% |
| Q4 2020 | 22 | 34 | 64.71% |
| Q3 2020 | 18 | 25 | 72.00% |
| Q2 2020 | 28 | 41 | 68.29% |
| Q1 2020 | 17 | 17 | 100.00% |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 21 | 9 | 233.33% |
| Q2 2019 | 8 | 22 | 36.36% |
18 total buy trades, and 107 total sell trades (buy/sell ratio of 0.17%) were made by Karuna Therapeutics's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 5 | - |
| Q4 2023 | - | 12 | - |
| Q3 2023 | - | 26 | - |
| Q2 2023 | - | 10 | - |
| Q1 2023 | - | 7 | - |
| Q4 2022 | - | 12 | - |
| Q3 2022 | - | 11 | - |
| Q2 2022 | 7 | 7 | 100.00% |
| Q1 2022 | - | 7 | - |
| Q4 2021 | - | 20 | - |
| Q3 2021 | 3 | 13 | 23.08% |
| Q2 2021 | - | 14 | - |
| Q1 2021 | - | 8 | - |
| Q4 2020 | - | 12 | - |
| Q3 2020 | 7 | 12 | 58.33% |
| Q2 2020 | - | 18 | - |
| Q1 2020 | 8 | 5 | 160.00% |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 7 | - | - |
| Q2 2019 | 2 | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 5 open market sell trades of Karuna Therapeutics's stocks.
Karuna Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| DYN | Dyne Therapeutics, Inc. |
| MREO | Mereo BioPharma Group plc |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| CYTK | Cytokinetics, Incorporated |
| AMLX | Amylyx Pharmaceuticals, Inc. |
KRTX Ownership FAQ
Who Owns Karuna Therapeutics?
Karuna Therapeutics is owned by institutional shareholders (0.00%), insiders (4.99%), and public (95.01%). The largest institutional shareholder of Karuna Therapeutics is IFP ADVISORS, INC (0% of total shares) and the top mutual fund owner is Manager Directed Portfolios (0.32% of total shares).
Who are the major institutional shareholders of Karuna Therapeutics?
Karuna Therapeutics's major institutional shareholders are IFP ADVISORS, INC, EVERSOURCE WEALTH ADVISORS, LLC, and SACHETTA, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Karuna Therapeutics shareholders are there?
As of Mar 2024, there are 3 institutional shareholders of Karuna Therapeutics.
What percentage of Karuna Therapeutics is owned by IFP ADVISORS, INC?
IFP ADVISORS, INC owns 0 shares of Karuna Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of Karuna Therapeutics is owned by EVERSOURCE WEALTH ADVISORS, LLC?
As of Jun 2024, EVERSOURCE WEALTH ADVISORS, LLC holds 0 shares of Karuna Therapeutics (KRTX), compromising 0% of the company, valued at $0.
What percentage of Karuna Therapeutics is owned by SACHETTA, LLC?
SACHETTA, LLC is the third largest holder of Karuna Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).